Document is current
Any future updates will be listed below
-
Authors
Cole, Connor https://orcid.org/0000-0003-4641-0104
Amber, Kyle
-
Funding
Funding for this research was provided by:
Office of Research Infrastructure Programs, National Institutes of Health (R21OD030057)
- License Information
-
More Information
Article History
Accepted: 15 August 2022
First Online: 2 September 2022
Declarations
:
: KTA has served as a consultant for Astra Zeneca, Argenx, and Akari therapeutics. KTA has received research funding from Astra Zeneca and Kabafusion.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
